Largest genome sequencing database released globally

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. 

Initial results from the largest completed population genome sequencing effort to date have been made available to the global scientific community to boost the search for rare genetic variants that increase the risk of disease.

“We are making all of these data available to the scientific community, which in terms of a resource is a quantum leap,” said Nicole Soranzo, a geneticist at the Wellcome Trust’s Sanger Institute in Cambridge.

Launched in 2010, the UK10K project was set up to study the genetic code of 10,000 people in much finer detail than ever before in order to uncover rare genetic variants, changes in DNA that are carried only by relatively a few people in a population, and how they contribute to human disease and its risk factors.

The project carried out whole genome sequencing at low coverage of 4000 healthy people and has published this information in Nature alongside detailed phenotypic information, a person’s observable clinical features e.g. height, blood pressure.

Previous studies have analysed either very rare genetic variants with big effects or common variants, which usually have small effects. The UK10K project has enabled researchers to explore more of the spectrum of variation between the very rare and the common ones, according to Richard Durbin, senior UK10K researcher at the Sanger Institute.

A key finding of the project was 24 million new genetic variants from healthy Europeans, which reflects the genetic diversity of the population.

Read full, original post: UK 10K genomes project shares its data

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Professional Portrait Earth Backdrop
Viewpoint: November 13 is the long-predicted global doomsday. How a respected scientist got population growth catastrophe predictions so spectacularly wrong—fueling decades of junk science
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ADA Lanyard on Woodgrain Desk
How the Trumpification of medicine is roiling — and maybe destroying—the American Diabetes Association
Tropical Yacht Conversation
Kennedy faces Congressional ethics investigation for accepting massive gifts from anti-vaccine and ketamine wellness grifter
Fluorescent and Natural Leaf Comparison
Here’s how biotechnology can reduce threats from disease and pests without resorting to sometimes-problematic chemicals
Data Center Power and Cost Surge
It’s the ‘juice’: What the AI data center wars are really all about
Energetic Speaker on Stage
Viewpoint: Why are the stars of the MAHA revolution standing by convicted rapist — and conservative firebrand — Russell Brand?
Testosterone-and-NATO-Editorial-Collage
Unintended consequences: Hegseth’s proposed controversial ‘low testosterone’ screen could flag 150,000 Army men. What happens next?  
Paper Field Portraits with Distant Barn (1)
Viewpoint: After MAHA-Republican election debacle, controversial campaigner Zen Honeycutt looks to sympathetic Democrats to promote her anti-chemical agenda
gmos africa
Slow adoption: Only 15 of Africa’s 54 nations embrace genetic engineering food revolution. Here’s why
Colorful GLP-1 Pens with Clocks_tagger
Biohacker influencers are claiming GLP-1 weight loss drugs extend lifespan. One mice experiment suggests there may be some truth to the claim
Neon Binary Code Bacteriophage
AI medicine breakthrough: Could ‘good viruses’ created by AI cure deadly diseases and infections?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.